Qualigen Therapeutics Inc

0.00 (+0.23%)
4:55:13 PM EDT: $0.52 -0.04 (-7.18%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)19.77M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.2 Million
Adjusted EPS-$0.16
See more estimates
10-Day MA$0.57
50-Day MA$0.56
200-Day MA$0.89
See more pivots

Qualigen Therapeutics Inc Stock, NASDAQ:QLGN

2042 Corte Del Nogal, Suite 3000, Carlsbad, California 92011
United States of America
Phone: +1.760.918.9165
Number of Employees: 46


Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. RAS-F3 is a small molecule RAS oncogene protein-protein inhibitor for blocking RAS mutations that lead to tumor formation, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device for removal from circulating blood of precisely targeted tumor-produced and viral compounds. The company was founded on March 29, 2004 and is headquartered in Carlsbad, CA.